pyridoxal has been researched along with Diabetic Nephropathies in 1 studies
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyoshi, H | 1 |
| Taguchi, T | 1 |
| Sugiura, M | 1 |
| Takeuchi, M | 1 |
| Yanagisawa, K | 1 |
| Watanabe, Y | 1 |
| Miwa, I | 1 |
| Makita, Z | 1 |
| Koike, T | 1 |
1 other study available for pyridoxal and Diabetic Nephropathies
| Article | Year |
|---|---|
Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice.
Topics: Animals; Azo Compounds; Benzoates; Blood Glucose; Body Weight; Diabetic Nephropathies; Glycation End | 2002 |